Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Cellular and Molecular Life Sciences : CMLS|April 18, 2024
Vascular mimicry as a facilitator of melanoma brain metastasisOlivia K Provance, Victor O Oria, Thuy T Tran, et al.
Frontiers in Oncology|February 21, 2024
Immunotherapy utilization in stage IIIA melanoma: less may be moreAlexander E Frey, Daniel M Kerekes, Sajid A Khan, et al.
Molecular Imaging|November 4, 2020
[<sup>11</sup>C]Methionine and [<sup>11</sup>C]PBR28 as PET Imaging Tracers to Differentiate Metastatic Tumor Recurrence or Radiation NecrosisThuy T Tran, Jean-Dominique Gallezot, Lucia B Jilaveanu, et al.
JAMA Oncology|January 4, 2024
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the USDaniel M Kerekes, Alexander E Frey, Elizabeth H Prsic, et al.
Cellular and Molecular Life Sciences : CMLS|June 23, 2022
Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanomaVictor O Oria, Hongyi Zhang, Christopher R Zito, et al.
Food Microbiology|November 28, 2016
MRSA and multidrug-resistant Staphylococcus aureus in U.S. retail meats, 2010-2011Beilei Ge, Sampa Mukherjee, Chih-Hao Hsu, et al.
Cancers|April 3, 2021
Clinical Significance of PDCD4 in Melanoma by Subcellular Expression and in Tumor-Associated Immune CellsThuy T Tran, Chetan K Rane, Christopher R Zito, et al.
JCI Insight|October 22, 2025
Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1Thuy T Tran, Gabriela Athziri Sánchez-Zuno, Lais Osmani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2026
Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase 2b KEYNOTE-942 StudyAdnan Khattak, Matteo S Carlino, Tarek Meniawy, et al.
Pageof 4